For the Inventor, By the Inventor

Enter assignee name

Shandong Luye Pharmaceutical Co., Ltd.

USPTO Granted Patents = 20

CIPO Patents = 3

EPO Patents = 13

Trademarks = 7

Forward Citations = 7

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

48 inventors (with patents filed for the assignee):

Wanhui Liu (9 out of 12 patents)

Youxin Li (8 out of 13 patents)

Kaoxiang Sun (7 out of 9 patents)

4. Rongcai Liang (5 out of 5 patents)

5. Wenyan Wang (5 out of 5 patents)

6. Mina Yang (5 out of 6 patents)

7. Qilin Wang (5 out of 5 patents)

8. Tao Wang (5 out of 14 patents)

9. Luping Zhang (4 out of 4 patents)

10. Jun Li (2 out of 85 patents)

11. Yongtao Jiang (2 out of 2 patents)

12. Ying Meng (2 out of 4 patents)

13. Qian Qian Xu (2 out of 2 patents)

14. Xin Shao (2 out of 2 patents)

15. Chunjie Sha (2 out of 4 patents)

20 patents: Sort by Forward Citations

1. 11124523 - 2,6-dioxaspiro [4,5] decane derivatives and preparation method therefor and pharmaceutical applications thereof (2021-09-21),

2. 11111227 - Rotigotine behenate, and manufacturing method and application thereof (2021-09-07),

3. 11110094 - Risperidone sustained release microsphere composition (2021-09-07),

4. 10669249 - Rotigotine behenate, and manufacturing method and application thereof (2020-06-02),

5. 10406161 - Risperidone sustained release microsphere composition (2019-09-10),

6. 10258572 - Pharmaceutical compositions of goserelin sustained release microspheres (2019-04-16),

7. 10098882 - Risperidone sustained release microsphere composition (2018-10-16),

8. 9532991 - Risperidone sustained release microsphere composition (2017-01-03),

9. 9446135 - Risperidone sustained release microsphere composition (2016-09-20),

10. 9265835 - Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative (2016-02-23),

11. 9220782 - Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof (2015-12-29),

12. 9199912 - Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods of preparing the same and use of the same (2015-12-01),

13. 9012660 - 5,6,7,8-tetrahydro-6-[N,N-bis[(2-thienyl)ethyl]] amino-1-naphthol, and preparing method and use thereof (2015-04-21),

14. 8809590 - Method for industrially preparing nitrogen substituted amino-5,6,7,8-tetrahydronaphthol (2014-08-19),

15. 8691277 - Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof (2014-04-08),

Shandong Luye Pharmaceutical Co., Ltd. is a leading pharmaceutical company based in China. With a strong focus on research and development, the company specializes in the production and sale of innovative and high-quality pharmaceutical products. Luye Pharma aims to provide effective healthcare solutions to improve the well-being of people worldwide. The company's commitment to quality and innovation has earned it a reputable position in the global pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

20 Patents

#3 in

#1,301 in

#30,309 in the World

Shandong Luye Pharmaceutical Co., Ltd.

Forward Citations = 7

48 inventors:

Wanhui Liu (9 out of 12 patents)

Youxin Li (8 out of 13 patents)

Kaoxiang Sun (7 out of 9 patents)

4. Rongcai Liang (5 out of 5 patents)

5. Wenyan Wang (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…